MULTIPLE MYELOMA PROGRESSION
Clinical trials for MULTIPLE MYELOMA PROGRESSION explained in plain language.
Never miss a new study
Get alerted when new MULTIPLE MYELOMA PROGRESSION trials appear
Sign up with your email to follow new studies for MULTIPLE MYELOMA PROGRESSION, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
One-Shot gene therapy trial offers hope for Hard-to-Treat blood cancer
Disease control Recruiting nowThis early-stage trial is testing the safety of a new gene therapy called KLN-1010 for people with multiple myeloma that has returned after multiple treatments. The therapy aims to reprogram the patient's own immune cells inside their body to attack cancer cells. Researchers will…
Matched conditions: MULTIPLE MYELOMA PROGRESSION
Phase: PHASE1 • Sponsor: Kelonia Therapeutics, Inc. • Aim: Disease control
Last updated Mar 13, 2026 15:05 UTC
-
Can early comfort care ease the burden of blood cancer?
Symptom relief Recruiting nowThis study is testing if adding early palliative (comfort) care to standard cancer treatment improves well-being for patients with multiple myeloma or aggressive lymphoma. It will involve 144 patients, and some of their caregivers, who will be randomly assigned to receive either …
Matched conditions: MULTIPLE MYELOMA PROGRESSION
Phase: NA • Sponsor: University Health Network, Toronto • Aim: Symptom relief
Last updated Mar 30, 2026 14:32 UTC
-
Major charlotte study hunts for early blood cancer signs before It's too late
Knowledge-focused Recruiting nowThis study aims to find early signs of multiple myeloma, a type of blood cancer, in people before they develop symptoms. Researchers will screen over 1,600 adults in the Charlotte area who are at higher risk, primarily focusing on Black/African American individuals and relatives …
Matched conditions: MULTIPLE MYELOMA PROGRESSION
Sponsor: Wake Forest University Health Sciences • Aim: Knowledge-focused
Last updated Apr 01, 2026 14:41 UTC